We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Life Science Technology Megatrends Shaping Our Future
Blog

Megatrends are overarching trends, ones that seed and embrace multiple market and technology developments. These trends already exist in our world today but are going to be even more important in the years to come. Here we highlight three technology megatrends that could be highly significant to our future.

Read More

Cell Conversions Transformed From Black Box Guesswork to Systematic Discovery
Blog

Predicting the reprogramming factors necessary to induce cell conversion has largely relied on trial and error, revealing the need for a more systematic approach.

To learn more about Mogrify's approach to achieving cell conversion through transdifferentiation, we interviewed Pierre-Louis Joffrin, Corporate Development Executive at Mogrify.

Read More

Exploring the Fourth Dimension of Proteome Analysis
Blog

Recent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.


Read More

Talking Clinical Proteomics With Dr Roman Fischer
Blog

Technology Networks spoke with Dr Roman Fischer to learn more about the challenges researchers face in the field of clinical proteomics, and how 4D proteomics workflows are enhancing his laboratory's work.

Read More

Digital Technology Enhancing Lateral Flow Diagnostics
Blog

Digitization is a trend threading many disciplines, and lateral flow is no exception. Here, we share insights from Dave Taylor, co-founder and chief operating officer of Bond Digital Health, a UK-based life sciences company that develops app and cloud technology solutions for lateral flow diagnostics.

Read More

10 Things to Note About Manufacturing Viral Vectors
Blog

10 things to note about viral vector manufacturing, regarding the complexities and challenges, and the technology that will help drive cell and gene therapy forward. Here we share insights from Pall and Molmed representatives, who are leaders in the fields of bioprocessing and cell and gene therapy.

Read More

Using Artificial Intelligence to Identify Bloodborne Bacteria
Blog

Fluid Imaging Technologies and the University of Colorado Boulder have recently entered an exclusive research agreement to determine whether the University’s artificial intelligence software can identify bloodborne bacteria. We spoke with Kent Peterson, CEO, Fluid Imaging Technologies, to learn more about the collaboration, the technologies involved, and how they could impact patients.

Read More

Building Better Neural Networks
Blog

Given the brain's complexity, it's no surprise that deep neural networks (DNN), computing system based on the brain, are challenging to design and improve. That is a challenge that companies like DarwinAI are meeting head-on. We talked to Sheldon Fernandez, DarwinAI’s CEO, to find out more.

Read More

Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata
Blog

We recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific. Previously, Quagliata was involved in one of the first teams in Europe to introduce Next Generation Sequencing (NGS) in routine molecular diagnostics. Here, he shares his perspectives on the field, particularly the use of NGS in the analysis of liquid biopsies, the discovery of cancer biomarkers and the potential application of artificial intelligence (AI) in molecular diagnostics.

Read More

Pharma-backed Toolkit to Speed Up Adoption of FAIR Data Principles
Blog

FAIR is a set of data principles that hopes to form a gold standard for scientific data management. Non-profit the Pistoia Alliance has developed a toolkit to help companies adopt FAIR. We spoke to Pistoia's Ian Harrow to find out more.

Read More